[
    [
        {
            "time": "2020-06-15",
            "original_text": "Eli Lilly (LLY) Flat As Market Gains: What You Should Know",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "LLY",
                    "Flat",
                    "Market Gains"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly (LLY) Flat As Market Gains: What You Should Know",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Coronavirus update: Global death tally tops 400,000; health experts urge police to stop using tear gas on anti-racism protesters",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "Global death tally",
                    "tear gas",
                    "anti-racism protesters"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "public policy"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Coronavirus update: Global death tally tops 400,000; health experts urge police to stop using tear gas on anti-racism protesters",
                "Correlation": 2,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Eli Lilly Kicks Off a Clinical Trial for a Second COVID-19 Antibody Treatment",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Clinical Trial",
                    "COVID-19",
                    "Antibody Treatment"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly Kicks Off a Clinical Trial for a Second COVID-19 Antibody Treatment",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Merck's Antibiotic Recarbrio Gets FDA Nod for New Indication",
            "features": {
                "keywords": [
                    "Merck",
                    "Antibiotic",
                    "Recarbrio",
                    "FDA",
                    "Nod",
                    "New Indication"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Merck's Antibiotic Recarbrio Gets FDA Nod for New Indication",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "LLY",
                    "Medical Stocks",
                    "Outpaced"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Lilly to Participate in Goldman Sachs Global Healthcare Conference",
            "features": {
                "keywords": [
                    "Lilly",
                    "Goldman Sachs",
                    "Global Healthcare Conference"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly to Participate in Goldman Sachs Global Healthcare Conference",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment",
            "features": {
                "keywords": [
                    "Lilly",
                    "Phase 1 Study",
                    "COVID-19",
                    "Antibody Treatment"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-06-15",
            "original_text": "Junshi Biosciences Kicks Off China’s First Covid-19 Antibody Trial",
            "features": {
                "keywords": [
                    "Junshi Biosciences",
                    "Covid-19",
                    "Antibody Trial",
                    "China"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Junshi Biosciences Kicks Off China’s First Covid-19 Antibody Trial",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]